Double Medical Technology Inc. (SHE:002901)
China · Delayed Price · Currency is CNY 58.20
+3.81 (7.00%)
Sep 8, 2025, 2:45 PM CST
Double Medical Technology Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2016 - 2020 |
Net Income | 462.82 | 356.8 | 58.96 | 92.56 | 673.31 | 605.68 | Upgrade |
Depreciation & Amortization | 128.66 | 122.8 | 111.9 | 95.51 | 70.85 | 50.33 | Upgrade |
Other Amortization | 107.14 | 99.37 | 82.49 | 42 | 11.2 | 1.25 | Upgrade |
Loss (Gain) From Sale of Assets | -0.26 | -0.27 | -0.3 | 1.73 | 0 | 0.12 | Upgrade |
Asset Writedown & Restructuring Costs | 0.54 | 0.93 | 0.88 | 1.91 | 0.94 | 0.06 | Upgrade |
Loss (Gain) From Sale of Investments | -27.32 | -20.39 | -15.35 | -17.98 | -21.41 | -7.33 | Upgrade |
Provision & Write-off of Bad Debts | 5.25 | 6.02 | -1.13 | -2.07 | 16.24 | 8.3 | Upgrade |
Other Operating Activities | 70.64 | 64.83 | 57.46 | 4.52 | 18.43 | 1.65 | Upgrade |
Change in Accounts Receivable | -11.56 | 4.64 | 86.8 | 121.91 | -179.38 | -69.35 | Upgrade |
Change in Inventory | -216.02 | -220.53 | -422.18 | -418.26 | -140.44 | -91.31 | Upgrade |
Change in Accounts Payable | 25.04 | 26.68 | 118.18 | 103.13 | 189.28 | 44.54 | Upgrade |
Change in Other Net Operating Assets | 30.72 | 7.87 | - | 105.55 | 38.08 | 13.41 | Upgrade |
Operating Cash Flow | 571.24 | 442.3 | 73.89 | 128.44 | 673.26 | 555.77 | Upgrade |
Operating Cash Flow Growth | 115.67% | 498.58% | -42.47% | -80.92% | 21.14% | 28.09% | Upgrade |
Capital Expenditures | -186.59 | -270.46 | -305.72 | -285.07 | -235.11 | -137.13 | Upgrade |
Sale of Property, Plant & Equipment | 0.89 | 1.37 | 1.59 | 0.44 | 0.01 | 0.1 | Upgrade |
Cash Acquisitions | - | - | - | 1.66 | -88.02 | - | Upgrade |
Investment in Securities | 233.21 | 406.86 | -213.77 | 40.75 | -96.03 | -143.72 | Upgrade |
Other Investing Activities | 6.89 | 13.75 | 9.89 | 16.74 | 22.59 | 4.63 | Upgrade |
Investing Cash Flow | 51.22 | 153.6 | -508.01 | -225.61 | -396.76 | -276.12 | Upgrade |
Long-Term Debt Issued | - | 159.05 | 532.61 | 50.77 | 1.11 | - | Upgrade |
Total Debt Issued | 110.04 | 159.05 | 532.61 | 50.77 | 1.11 | - | Upgrade |
Long-Term Debt Repaid | - | -377.83 | -12.33 | -11.36 | -8.33 | - | Upgrade |
Total Debt Repaid | -207.67 | -377.83 | -12.33 | -11.36 | -8.33 | - | Upgrade |
Net Debt Issued (Repaid) | -97.62 | -218.78 | 520.28 | 39.41 | -7.22 | - | Upgrade |
Issuance of Common Stock | - | - | - | 488.32 | 79.34 | - | Upgrade |
Repurchase of Common Stock | -234.98 | -234.98 | - | -75.68 | -2.92 | -2.35 | Upgrade |
Common Dividends Paid | -254.77 | -118.07 | -9.43 | -209.38 | -324.11 | -241.34 | Upgrade |
Other Financing Activities | -57.62 | -45.37 | -14.65 | 2.5 | -4.42 | -11.95 | Upgrade |
Financing Cash Flow | -644.99 | -617.2 | 496.2 | 245.16 | -259.33 | -255.64 | Upgrade |
Foreign Exchange Rate Adjustments | -5.78 | -11.37 | 1.06 | 4.31 | -3.55 | -13.48 | Upgrade |
Net Cash Flow | -28.32 | -32.68 | 63.14 | 152.3 | 13.61 | 10.53 | Upgrade |
Free Cash Flow | 384.65 | 171.84 | -231.82 | -156.63 | 438.15 | 418.64 | Upgrade |
Free Cash Flow Growth | - | - | - | - | 4.66% | 265.34% | Upgrade |
Free Cash Flow Margin | 16.15% | 8.05% | -15.12% | -10.92% | 21.97% | 26.38% | Upgrade |
Free Cash Flow Per Share | 0.94 | 0.41 | -0.55 | -0.37 | 1.09 | 1.04 | Upgrade |
Cash Income Tax Paid | 253.6 | 175.28 | 106.5 | 210.18 | 310.97 | 240.93 | Upgrade |
Levered Free Cash Flow | 221.26 | 73.43 | -105.63 | -240.44 | 303.33 | 173.7 | Upgrade |
Unlevered Free Cash Flow | 224.93 | 77.48 | -101.16 | -238.5 | 303.68 | 173.7 | Upgrade |
Change in Working Capital | -176.21 | -187.8 | -221.01 | -89.74 | -96.3 | -104.3 | Upgrade |
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.